Biotherapy Services Limited MHRA approves the RAPID-1DFU clinical trial Company is progressing as planned towards Q1/2019 clinical trials. 8thNovember 2018, Biotherapy Services Ltd. the specialist wound healing service company, today announces that it has secured regulatory approval from the Medicines and Healthcare Regulatory Agency (MHRA) for the commencement...
Biotherapy Services Limited We are pleased to announce the appointment of James Rickard as Chief Scientific and Regulatory Officer James has over 17 years’ experience as a clinical pharmacist leading technical services and clinical trials within the NHS. Most recently James was the Deputy chief pharmacist for Barts...
Biotherapy Services Limited MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment. Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018 For further information,...